Granville Matheson

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: IMAGING NEUROSCIENCE. 2024;2:1-16
PET imaging of the serotonin 1A receptor in major depressive disorder: Hierarchical multivariate analysis of [11C]WAY100635 overcomes outcome measure discrepancies
Matheson GJ; Zanderigo F; Miller JM; Bartlett EA; Mann JJ; Ogden RT
Article: JOURNAL OF OPEN SOURCE SOFTWARE. 2024;9(100):6067
PET2BIDS: a library for converting Positron Emission Tomography data to BIDS.
Galassi A; Norgaard M; Thomas AG; Gonzalez-Escamilla G; Svarer C; Rorden C; Matheson GJ; Knudsen GM; Innis RB; Ganz M; Eierud C; Bilgel M; Pernet C
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2024;27(5):pyae021
Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect
Garde M; Matheson GJ; Varnaes K; Svenningsson P; Hedman-Lagerloef E; Lundberg J; Farde L; Tiger M
Article: IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING. 2024;71(4):1191-1196
Nonlinear Mixed-Effects Modeling Approach for Simplified Reference Tissue Model
Shieh D; Matheson GJ; Ogden RT
Article: EJNMMI PHYSICS. 2023;10(1):72
Parametric and non-parametric Poisson regression for modelling of the arterial input function in positron emission tomography
Matheson GJ; Ge L; Zhang M; Sun B; Tu Y; Zanderigo F; Moren AF; Ogden RT
Article: ADDICTION. 2023;118(6):1053-1061
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers
Jangard S; Jayaram-Lindstrom N; Isacsson NH; Matheson GJ; Plaven-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Article: EJNMMI PHYSICS. 2023;10(1):17
Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency
Matheson GJJ; Ogden RT
Article: BRAIN SCIENCES. 2022;12(10):1338
Experimental Sleep Deprivation Results in Diminished Perceptual Stability Independently of Psychosis Proneness
Balter LJT; Matheson GJ; Sundelin T; Sterzer P; Petrovic P; Axelsson J
Article: NEUROIMAGE. 2022;256:119195
Simultaneous multifactor Bayesian analysis (SiMBA) of PET time activity curve data
Matheson GJ; Ogden RT
Article: THE LANCET PSYCHIATRY. 2022;9(6):447-457
Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden
Millischer V; Matheson GJ; Bergen SE; Coombes BJ; Ponzer K; Wikstrom F; Jagiello K; Lundberg M; Stenvinkel P; Biernacka JM; Breuer O; Martinsson L; Landen M; Backlund L; Lavebratt C; Schalling M
Article: SCIENTIFIC DATA. 2022;9(1):65
PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
Norgaard M; Matheson GJ; Hansen HD; Thomas A; Searle G; Rizzo G; Veronese M; Giacomel A; Yaqub M; Tonietto M; Funck T; Gillman A; Boniface H; Routier A; Dalenberg JR; Betthauser T; Feingold F; Markiewicz CJ; Gorgolewski KJ; Blair RW; Appelhoff S; Gau R; Salo T; Niso G; Pernet C; Phillips C; Oostenveld R; Gallezot J-D; Carson RE; Knudsen GM; Innis RB; Ganz M
Article: MOLECULAR PSYCHIATRY. 2022;27(2):1233-1240
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
Plaven-Sigray P; Ikonen Victorsson P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Sellgren CM; Erhardt S; Agartz I; Halldin C; Farde L; Cervenka S
Article: HEPATOLOGY. 2021;74(6):3301-3315
Test-Retest Reliability and Consistency of HVPG and Impact on Trial Design: A Study in 289 Patients from 20 Randomized Controlled Trials
Bai W; Al-Karaghouli M; Stach J; Sung S; Matheson GJ; Abraldes JG
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;294:645-651
A positron emission tomography study of the serotonin1B receptor effect of electroconvulsive therapy for severe major depressive episodes
Tiger M; Garde M; Tateno A; Matheson GJ; Sakayori T; Nogami T; Moriya H; Varnas K; Arakawa R; Okubo Y
Article: NEUROIMAGE. 2021;226:117523
Low convergent validity of [¹¹C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [¹¹C]FLB 457
Freiburghaus T; Svensson JE; Matheson GJ; Plaven-Sigray P; Lundberg J; Farde L; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):95
Reliability of dopamine transporter PET measurements with [¹⁸F]FE-PE2I in patients with Parkinson's disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Article: SCHIZOPHRENIA RESEARCH. 2020;222:175-184
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plaven-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):77
Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Journal article: SCHIZOPHRENIA BULLETIN. 2020;46(Supplement_1):s135-s136
M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
Victorsson P; Plavén-Sigray P; Matheson G; Santillo A; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Journal article: SCHIZOPHRENIA BULLETIN. 2020;46(Supplement_1):s233
T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
Plavén-Sigray P; Matheson G; Coughlin J; Hafizi S; Laurikainen H; Ottoy J; de’Picker L; Rusjan P; Hietala J; Howes O; Mizrahi R; Morrens M; Pomper M; Cervenka S
Article: PSYCHIATRY RESEARCH. 2020;284:112677
AKT1 and genetic vulnerability to bipolar disorder
Millischer V; Matheson GJ; Martinsson L; Ek IR; Schalling M; Lavebratt C; Backlund L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(7):415-425
D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Article: PEERJ. 2019;7:e6918
We need to talk about reliability: making better use of test-retest studies for study design and interpretation
Matheson GJ
Article: EJNMMI RESEARCH. 2018;8(1):102
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plaven-Sigray P; Matheson GJ; Cselenyi Z; Jucaite A; Farde L; Cervenka S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(6):433-442
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
Plaven-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Article: EJNMMI RESEARCH. 2018;8(1):74
[¹¹C]SCH23390 binding to the D₁-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis
Stenkrona P; Matheson GJ; Cervenka S; Sigray PP; Halldin C; Farde L
Article: PEERJ. 2018;6:e5790
Serotonin 5-HT₁_A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Article: PLOS ONE. 2018;13(12):e0209584
Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
Caravaggio F; Plaven-Sigray P; Matheson GJ; Plitman E; Chakravarty MM; Borg J; Graff-Guerrero A; Cervenka S
Article: PLOS ONE. 2018;13(3):e0193770
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plaven-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Article: EJNMMI RESEARCH. 2017;7(1):58
Assessment of simplified ratio-based approaches for quantification of PET [¹¹C] PBR28 data
Matheson GJ; Plaven-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
Article: ELIFE. 2017;6:e27725
The readability of scientific texts is decreasing over time
Plaven-Sigray P; Matheson GJ; Schiffler BC; Thompson WH
Article: NEUROIMAGE. 2017;155:344-353
Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [¹¹C] SCH-23390
Matheson GJ; Stenkrona P; Cselenyi Z; Plaven-Sigray P; Halldin C; Farde L; Cervenka S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):462-469
Extrastriatal dopamine D2-receptor availability in social anxiety disorder
Plaven-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Ruck C; Halldin C; Lindefors N; Cervenka S
Article: MOLECULAR PSYCHIATRY. 2016;21(8):1077-1084
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Article: NEUROIMAGE. 2015;112:225-231
Diurnal and seasonal variation of the brain serotonin system in healthy male subjects
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Visa fler

Alla övriga publikationer

Preprint: MEDRXIV. 2024
Trajectories of Cognitive Function in First-Episode Psychosis: Associations to Clinical Outcomes and Biomarkers
Lee M; Cullen AE; Matheson GJ; Lu Z-A; Bergen SE; Sellgren CM; Erhardt S; Fatouros-Bergman H; Cervenka S
Preprint: BIORXIV. 2024;BIORXIV
PET Imaging of the Serotonin 1A Receptor in Major Depressive Disorder: Hierarchical Multivariate Analysis of [11C]WAY100635 Overcomes Outcome Measure Discrepancies.
Matheson GJ; Zanderigo F; Miller JM; Bartlett EA; Mann JJ; Ogden RT
Preprint: BIORXIV. 2022
Multivariate Analysis of PET Pharmacokinetic Parameters
Matheson G; Ogden T
Preprint: BIORXIV. 2021
PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
Norgaard M; Matheson G; Hansen H; Thomas A; Searle G; Rizzo G; Veronese M; Giacomel A; Yaqub M; Tonietto M; Funck T; Gillman A; Boniface H; Routier A; Dalenberg J; Betthauser T; Feingold F; Markiewicz C; Gorgolewski K; Blair R; Appelhoff S; Gau R; Salo T; Niso G; Pernet C; Phillips C; Oostenveld R; Gallezot J-D; Carson R; Knudsen G; Innis R; Ganz M
Letter: BIOLOGICAL PSYCHIATRY. 2021;89(3):e5-e8
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; De Picker L; Rusjan P; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):117-119
The positron emission tomography brain imaging data structure (PET-BIDS) extension: A new standard for sharing PET data
Norgaard M; Matheson GJ; Hansen HD; Thomas A; Searle G; Rizzo G; Veronese M; Giacomel A; Yaqub M; Tonietto M; Funck T; Gillman A; Boniface H; Routier A; Dalenberg JR; Betthauser T; Feingold F; Markiewicz CJ; Gorgolewski KJ; Blair RW; Appelhoff S; Gau R; Salo T; Niso G; Pernet C; Phillips C; Oostenveld R; Gallezot J-D; Carson RE; Knudsen GM; Innis RB; Ganz M
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):224-225
Strength in numbers: Multilevel modelling of time activity curves
Matheson GJ; Chen Y; Zanderigo F; Ogden RT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):131-132
Assessing neurobiological correlates of [¹¹C]WAY-100635 two-tissue compartment model parameters using SiMBA
Matheson GJ; Ogden RT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):121-122
Simultaneous Multifactor Bayesian Analysis (SiMBA) of PET Time Activity Curve Data
Matheson GJ; Ogden RT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):260-261
Lower thalamic dopamine D2-receptor binding and connectivity in drug-naive patients with psychosis - A combined [11C]FLB 457 PET and DTI study
Victorsson P; Plaven-Sigray P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):228-229
Meta-analysis of the glial marker TSPO in psychosis revisited: Reconciling inconclusive findings of patient-control differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; de'Picker L; Rusjan PM; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):258-260
Validation of kinfitr: An open-source tool for reproducible PET kinetic modelling
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Preprint: MEDRXIV. 2020
Test-retest reliability of hepatic venous pressure gradient and impact on trial design: a study in 289 patients from the control groups of 20 randomized trials
Bai W; Al-Karaghouli M; Stach J; Matheson GJ; Abraldes JG
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2020;40(8):1576-1585
Guidelines for the content and format of PET brain data in publications and archives: A consensus paper
Knudsen GM; Ganz M; Appelhoff S; Boellaard R; Bormans G; Carson RE; Catana C; Doudet D; Gee AD; Greve DN; Gunn RN; Halldin C; Herscovitch P; Huang H; Keller SH; Lammertsma AA; Lanzenberger R; Liow J-S; Lohith TG; Lubberink M; Lyoo CH; Mann JJ; Matheson GJ; Nichols TE; Norgaard M; Ogden T; Parsey R; Pike VW; Price J; Rizzo G; Rosa-Neto P; Schain M; Scott PJH; Searle G; Slifstein M; Suhara T; Talbot PS; Thomas A; Veronese M; Wong DF; Yaqub M; Zanderigo F; Zoghbi S; Innis RB
Preprint: RESEARCH SQUARE. 2020
Reliability of Dopamine Transporter PET Measurements with [18F]FE-PE2I in patients with Parkinson´s Disease
Kerstens V; Fazio P; Sundgren M; Matheson G; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Preprint: BIORXIV. 2020
Low convergent validity of [₁₁C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [₁₁C]FLB 457
Freiburghaus T; Svensson J; Matheson G; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Preprint: RESEARCH SQUARE. 2020
Reliability of Dopamine Transporter PET Measurements with [18F]FE-PE2I in patients with Parkinson's Disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Preprint: BIORXIV. 2020
Kinfitr – an open source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Letter: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(2):502-504
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
Matheson GJ; Plaven-Sigray P; Tuisku J; Rinne J; Matuskey D; Cervenka S
Conference publication: HEPATOLOGY. 2020;72:72A
TEST-RETEST RELIABILITY OF HEPATIC VENOUS PRESSURE GRADIENT IN 289 PATIENTS FROM THE CONTROL GROUPS OF 20 RANDOMIZED CONTROLLED TRIALS. IMPACT ON TRIAL DESIGN.
Bai W; Al-Karaghouli M; Stach J; Matheson G; Abraldes JG
Conference publication: SCHIZOPHRENIA BULLETIN. 2020;46:S135-S136
LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS - A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
Victorsson P; Plaven-Sigray P; Matheson G; Santillo A; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Conference publication: SCHIZOPHRENIA BULLETIN. 2020;46:S233
UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
Plaven-Sigray P; Matheson G; Coughlin J; Hafizi S; Laurikainen H; Ottoy J; de'Picker L; Rusjan P; Hietala J; Howes O; Mizrahi R; Morrens M; Pomper M; Cervenka S
Preprint: BIORXIV. 2019
kinfitr: Reproducible PET Pharmacokinetic Modelling in R
Matheson G
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(SUPPL 1):S392-S393
Reliability of Dopamine Transporter PET Measurements with [¹⁸F]FE-PE2I in Early Stage Parkinson's Disease: A Preliminary Test-Retest Evaluation
Kerstens V; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Thesis / dissertation: 2018
Reliability, replicability and reproducibility in PET imaging
Matheson, Granville James
Preprint: BIORXIV. 2018
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plavén-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Preprint: BIORXIV. 2018
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plavén-Sigray P; Matheson GJ; Cselényi Z; Jučaite A; Farde L; Cervenka S
Preprint: BIORXIV. 2018
We need to talk about reliability: Making better use of test-retest studies for study design and interpretation
Matheson G
Dataset: 2018
nls.multstart: Robust Non-Linear Regression using AIC Scores
Padfield D; Matheson G
Dataset: 2018
staplr: A Toolkit for PDF Files
Talagala PD; Mancarci O; Padfield D; Matheson G; Vinyals M
Preprint: BIORXIV. 2017
PET studies of the glial cell marker TSPO in psychosis patients - a meta-analysis using individual participant data
Plavén-Sigray P; Matheson G; Collste K; Ashok A; Coughlin J; Howes O; Mizrahi R; Pomper M; Rusjan P; Veronese M; Wang Y; Cervenka S
Preprint: BIORXIV. 2017
Serotonin 5-HT_1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Preprint: BIORXIV. 2017
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plavén-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Preprint: BIORXIV. 2017
The readability of scientific texts is decreasing over time
Plavén-Sigray P; Matheson GJ; Schiffler BC; Thompson WH
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:237
Serotonin 5HT_1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian inference
Griffioen G; Borg J; Matheson GJ; Cervenka S; Farde L
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:165-166
Assessment of the reliability and validity of simplified ratio-based quantification approaches for [¹¹C]PBR28
Matheson GJ; Sigray PP; Forsberg A; Collste K; Varrone A; Halldin C; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:677-678
ELEVATED LEVELS OF ORBITOFRONTAL DOPAMINE D2-RECEPTORS IN PATIENTS WITH SOCIAL ANXIETY DISORDER
Sigray PP; Hedman E; Ikonen P; Matheson G; Forsberg A; Djurfeldt D; Ruck C; Halldin C; Lindefors N; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:674-675
ASSESSING THE DOPAMINERGIC BASIS OF DELUSIONAL IDEATION: THE RELATIONSHIP BETWEEN D1 AND D2 RECEPTOR AVAILABILITY AND DELUSIONAL BELIEFS IN HEALTHY SUBJECTS
Matheson GJ; Louzolo A; Plaven-Sigray P; Stenkrona P; Farde L; Ingvar M; Petrovic P; Cervenka S
Conference publication: INTERNATIONAL JOURNAL OF PSYCHOLOGY. 2016;51:879
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:675-676
DIURNAL AND SEASONAL VARIATION OF THE BRAIN SEROTONIN SYSTEM IN HEALTHY MALE SUBJECTS
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:676
PET STUDY OF THALAMIC DOPAMINE D2-RECEPTORS IN DRUG-NAIVE PATIENTS WITH SCHIZOPHRENIA
Ikonen P; Cervenka S; Collste K; Fatouros-Bergman H; Matheson G; Sigray PP; Varrone A; Halldin C; Flyckt L; Farde L
Visa fler

Forskningsbidrag

A new approach for PET quantification using multilevel Bayesian modelling, and its application to study the neurobiology of depression
Swedish Research Council
1 January 2021 - 31 December 2023

Anställningar

Biträdande Lektor, Klinisk neurovetenskap, Karolinska Institutet, 2025-2030
Postdoktor, Klinisk neurovetenskap, Karolinska Institutet, 2022-2024

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2019

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI